Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Georges

Showing results (101-110 of 135) with videos related to

Pageof 14
Sort By:
Transplantation Proceedings|December 21, 2002
Survival of small bowel transplants in canine mixed hematopoietic chimeras: preliminary resultsM Y Yunusov, C Kuhr, G E Georges, et al.
Blood Advances|January 4, 2018
Tandem autologous/allogeneic hematopoietic cell transplantation with bortezomib maintenance therapy for high-risk myelomaDamian J Green, David G Maloney, Barry E Storer, et al.
Journal of Biotechnology|September 22, 2011
Transient proteasome inhibition as a strategy to enhance lentiviral transduction of hematopoietic CD34(+) cells and T lymphocytes: implications for the use of low viral doses and large-size vectorsValeria Leuci, Giulia Mesiano, Loretta Gammaitoni, et al.
Transplantation|September 14, 2006
Partial donor-specific tolerance to delayed skin grafts after rejection of hematopoietic cell graftMurad Y Yunusov, Christian S Kuhr, George E Georges, et al.
Leukemia & Lymphoma|March 23, 2016
Evaluation of allogeneic transplantation in first or later minimal residual disease - negative remission following adult-inspired therapy for acute lymphoblastic leukemiaRyan D Cassaday, D Alan Potts, Philip A Stevenson, et al.
Haematologica|April 22, 2011
Non-myeloablative conditioning with allogeneic hematopoietic cell transplantation for the treatment of high-risk acute lymphoblastic leukemiaRon Ram, Rainer Storb, Brenda M Sandmaier, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|June 29, 2018
Systemic Sclerosis as an Indication for Autologous Hematopoietic Cell Transplantation: Position Statement from the American Society for Blood and Marrow TransplantationKeith M Sullivan, Navneet S Majhail, Christopher Bredeson, et al.
Multiple Sclerosis and Related Disorders|July 20, 2021
Brain volume change after high-dose immunosuppression and autologous hematopoietic cell transplantation for relapsing-remitting multiple sclerosisHyunwoo Lee, Kunio Nakamura, Sridar Narayanan, et al.
Radiation Research|January 28, 2011
Identification of radiation-induced expression changes in nonimmortalized human T cellsEra L Pogosova-Agadjanyan, Wenhong Fan, George E Georges, et al.
Heliyon|January 29, 2024
Allogeneic bone marrow transplantation for patients with treatment-refractory Crohn's DiseaseGeorge B McDonald, Ole J B Landsverk, Dermot P B McGovern, et al.
Pageof 14

Showing results (101-110 of 135) with videos related to

Sort By:
Pageof 14
Transplantation Proceedings|December 21, 2002
Survival of small bowel transplants in canine mixed hematopoietic chimeras: preliminary resultsM Y Yunusov, C Kuhr, G E Georges, et al.
Blood Advances|January 4, 2018
Tandem autologous/allogeneic hematopoietic cell transplantation with bortezomib maintenance therapy for high-risk myelomaDamian J Green, David G Maloney, Barry E Storer, et al.
Journal of Biotechnology|September 22, 2011
Transient proteasome inhibition as a strategy to enhance lentiviral transduction of hematopoietic CD34(+) cells and T lymphocytes: implications for the use of low viral doses and large-size vectorsValeria Leuci, Giulia Mesiano, Loretta Gammaitoni, et al.
Transplantation|September 14, 2006
Partial donor-specific tolerance to delayed skin grafts after rejection of hematopoietic cell graftMurad Y Yunusov, Christian S Kuhr, George E Georges, et al.
Leukemia & Lymphoma|March 23, 2016
Evaluation of allogeneic transplantation in first or later minimal residual disease - negative remission following adult-inspired therapy for acute lymphoblastic leukemiaRyan D Cassaday, D Alan Potts, Philip A Stevenson, et al.
Haematologica|April 22, 2011
Non-myeloablative conditioning with allogeneic hematopoietic cell transplantation for the treatment of high-risk acute lymphoblastic leukemiaRon Ram, Rainer Storb, Brenda M Sandmaier, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|June 29, 2018
Systemic Sclerosis as an Indication for Autologous Hematopoietic Cell Transplantation: Position Statement from the American Society for Blood and Marrow TransplantationKeith M Sullivan, Navneet S Majhail, Christopher Bredeson, et al.
Multiple Sclerosis and Related Disorders|July 20, 2021
Brain volume change after high-dose immunosuppression and autologous hematopoietic cell transplantation for relapsing-remitting multiple sclerosisHyunwoo Lee, Kunio Nakamura, Sridar Narayanan, et al.
Radiation Research|January 28, 2011
Identification of radiation-induced expression changes in nonimmortalized human T cellsEra L Pogosova-Agadjanyan, Wenhong Fan, George E Georges, et al.
Heliyon|January 29, 2024
Allogeneic bone marrow transplantation for patients with treatment-refractory Crohn's DiseaseGeorge B McDonald, Ole J B Landsverk, Dermot P B McGovern, et al.
Pageof 14